Gómez B I, Gifford C A, Hallford D M, Hernandez Gifford J A
Department of Animal Science, Oklahoma State University, OK 74078, United States.
Department of Animal and Range Sciences, New Mexico State University, Las Cruces, NM 88003, United States.
Anim Reprod Sci. 2015 Dec;163:97-104. doi: 10.1016/j.anireprosci.2015.10.003. Epub 2015 Oct 19.
Follicle-stimulating hormone regulation of ovarian estradiol (E2) production requires involvement of beta-catenin (CTNNB1), a transcriptional co-factor. In cultured granulosa cells (GC) of cattle, FSH treatment increased protein abundance of CTNNB1 as well as protein kinase B (AKT), a molecule known to regulate components of the CTNNB1 degradation complex. However, whether FSH induction of CTNNB1 is through direct modulation of AKT remains to be determined. To investigate specific contributions of AKT to CTNNB1 accumulation, GC were treated with insulin-like growth factor-I (IGF-I), a well-established AKT activator, in the presence or absence of FSH. Granulosa cells treated with FSH, IGF-I, and IGF-I plus FSH had increased CTNNB1 accumulation compared with controls (P ≤ 0.02; n=6). E2 medium concentrations were greater (P=0.09; n=4) in FSH treated cells compared to controls (166 and 100 ± 28 pg/mL, respectively). Treatment with IGF-I and IGF-I plus FSH increased (P<0.01) E2 to comparable concentrations. Subsequently, GC treated with lithium chloride (LiCl), a pharmacological activator of AKT, provided a response consistent with IGF-I treated cells, as LiCl, FSH, and FSH plus LiCl increased CTNNB1 accumulation compared with non-treated controls (P ≤ 0.03; n=3). In contrast, inhibition of AKT signaling with LY294002 suppressed the ability of FSH and IGF-I to regulate CTNNB1. Additionally, LY294002 treatment reduced FSH and IGF-I mediated E2 medium concentrations (P ≤ 0.004). These results demonstrate that activation of AKT is required for gonadotropin regulation of CTNNB1 accumulation and subsequent ovarian E2 production.
促卵泡激素对卵巢雌二醇(E2)生成的调节需要转录共因子β-连环蛋白(CTNNB1)的参与。在培养的牛颗粒细胞(GC)中,促卵泡激素处理增加了CTNNB1以及蛋白激酶B(AKT)的蛋白丰度,AKT是一种已知可调节CTNNB1降解复合物成分的分子。然而,促卵泡激素对CTNNB1的诱导是否通过直接调节AKT仍有待确定。为了研究AKT对CTNNB1积累的具体作用,在有或没有促卵泡激素的情况下,用胰岛素样生长因子-I(IGF-I)(一种成熟的AKT激活剂)处理颗粒细胞。与对照组相比,用促卵泡激素、IGF-I以及IGF-I加促卵泡激素处理的颗粒细胞中CTNNB1积累增加(P≤0.02;n = 6)。与对照组相比,促卵泡激素处理的细胞中E2培养基浓度更高(P = 0.09;n = 4)(分别为166和100±28 pg/mL)。用IGF-I以及IGF-I加促卵泡激素处理使E2增加到可比浓度(P<0.01)。随后,用氯化锂(LiCl)(一种AKT的药理学激活剂)处理颗粒细胞,得到了与IGF-I处理细胞一致的反应,因为与未处理的对照组相比,LiCl、促卵泡激素以及促卵泡激素加LiCl增加了CTNNB1积累(P≤0.03;n = 3)。相反,用LY294002抑制AKT信号传导抑制了促卵泡激素和IGF-I调节CTNNB1的能力。此外,LY294002处理降低了促卵泡激素和IGF-I介导 的E2培养基浓度(P≤0.004)。这些结果表明,AKT的激活是促性腺激素调节CTNNB1积累以及随后卵巢E2生成所必需的。